Levothyroxine sodium
- Product NDC
- 67296-1908
- 11-digit product format
- 672961908
- Labeler code
- 67296
- Product ID
- 67296-1908_2c631b3a-4a1d-5890-e063-6394a90a6855
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levothyroxine Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RedPharm Drug, Inc
- Application
- ANDA212399
- Marketing category
- ANDA
- Marketing start
- 2020-11-25
- Substance
- LEVOTHYROXINE SODIUM
- Active strength
- 137 ug/1
- Pharmacologic classes
- Thyroxine [CS], l-Thyroxine [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
openFDA Listing Details
- Product ID
- 67296-1908_2c631b3a-4a1d-5890-e063-6394a90a6855
- SPL ID
- 2c631b3a-4a1d-5890-e063-6394a90a6855
- Product type
- HUMAN PRESCRIPTION DRUG
- Finished product
- Yes
- Brand name base
- Levothyroxine sodium
- Generic name
- Levothyroxine Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Marketing start
- 2020-11-25
- Marketing category
- ANDA
- Application number
- ANDA212399
- Pharmacologic classes
- Thyroxine [CS]; l-Thyroxine [EPC]
- Listing expiration
- 2026-12-31
openFDA Active Ingredients
| Ingredient | Strength |
|---|
| LEVOTHYROXINE SODIUM | 137 ug/1 |
openFDA Harmonized Identifiers
| Field | Values |
|---|
| Unii | 9J765S329G |
| Rxcui | 966270 |
| Spl Set Id | fcb196a2-31a6-437a-e053-6294a90a98ad |
| Manufacturer Name | RedPharm Drug, Inc |
openFDA Package Details
| Package NDC | Description | Marketing start | Sample |
|---|
| 67296-1908-3 | 30 TABLET in 1 BOTTLE (67296-1908-3) | 2020-11-25 | No |
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| 9J765S329G | LEVOTHYROXINE SODIUM | 6106-07-6 | LEVOTHYROXINE SODIUM |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 67296-1908-3 | 67296190803 | 30 TABLET in 1 BOTTLE (67296-1908-3) | 30 tablet | 2020-11-25 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Levothyroxine sodium | RedPharm Drug, Inc | 2025-01-23 | HUMAN PRESCRIPTION DRUG LABEL | 2 |